Sangamo Therapeutics, Inc.
SGMO
$0.5863
$0.01312.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 44.68% | 37.67% | 61.20% | 110.25% | 68.45% |
| Total Depreciation and Amortization | -26.27% | -23.83% | -29.05% | -71.33% | -58.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -66.11% | -51.87% | -56.87% | -93.42% | -86.93% |
| Change in Net Operating Assets | -16,707.14% | 98.97% | 1,858.75% | -67.30% | 100.42% |
| Cash from Operations | 32.46% | 46.27% | 93.37% | 124.86% | 55.72% |
| Capital Expenditure | -- | -- | 94.31% | 95.81% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -100.00% | -100.00% |
| Cash from Investing | -118.90% | -- | -96.49% | -99.38% | -99.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -54.00% | 3,238.43% | -100.00% | -- |
| Repurchase of Common Stock | 21.20% | -453.98% | -348.98% | -100.99% | -174.74% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,468.48% | -63.23% | 4,086.23% | -103.00% | -108.18% |
| Foreign Exchange rate Adjustments | 1,163.04% | 290.60% | -266.08% | 304.73% | -182.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 147.79% | -293.97% | 124.02% | 225.19% | -141.41% |